Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury
NCT04033952, Not applicable, Unknown, Taipei Medical University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury | ClinicalTrials.gov |
| NCT number | NCT04033952 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 180 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Taipei Medical University | ClinicalTrials.gov |
| Conditions | Cognitive Impairment, Stroke, Acquired Brain Injury | ClinicalTrials.gov |
| Interventions | Strategy Training | ClinicalTrials.gov |
| First posted | 2019-07-26 | ClinicalTrials.gov |
| Last updated | 2024-04-10 | ClinicalTrials.gov |
Registered outcomes 62
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stroop Test | Change from baseline to post-intervention within 1 week | Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published. | ClinicalTrials.gov |
| Primary | Trail-Making Test (TMT A and B) | Change from baseline to post-intervention within 1 week | Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations. | ClinicalTrials.gov |
| Primary | Montreal Cognitive Assessment (MoCA) | Change from baseline to post-intervention within 1 week | Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function. | ClinicalTrials.gov |
| Secondary | Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms | Change from baseline to post-intervention within 1 week | The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale. | ClinicalTrials.gov |
| Secondary | Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms | Change from post-intervention to 3 month follow-up, within 2 weeks | The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale. | ClinicalTrials.gov |
| Secondary | Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms | Change from 3 month to 6 month follow-up, within 2 weeks | The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale. | ClinicalTrials.gov |
| Secondary | Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms | Change from 6 month to 12 month follow-up, within 2 weeks | The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale. | ClinicalTrials.gov |
| Secondary | Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) | Change from baseline to post-intervention within 1 week | The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score. | ClinicalTrials.gov |
| Secondary | Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) | Change from post-intervention to 3 month follow-up, within 2 weeks | The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score. | ClinicalTrials.gov |
| Secondary | Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) | Change from 3 month to 6 month follow-up, within 2 weeks | The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score. | ClinicalTrials.gov |
| Secondary | Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) | Change from 6 month to 12 month follow-up, within 2 weeks | The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score. | ClinicalTrials.gov |
| Secondary | General Self Efficacy Scale (GSCS) | Change from baseline to post-intervention within 1 week | The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40. | ClinicalTrials.gov |
| Secondary | General Self Efficacy Scale (GSCS) | Change from post-intervention to 3 month follow-up, within 2 weeks | The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40. | ClinicalTrials.gov |
| Secondary | General Self Efficacy Scale (GSCS) | Change from 3 month to 6 month follow-up, within 2 weeks | The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40. | ClinicalTrials.gov |
| Secondary | General Self Efficacy Scale (GSCS) | Change from 6 month to 12 month follow-up, within 2 weeks | The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40. | ClinicalTrials.gov |
| Secondary | Canadian Occupational Performance Measure (COPM) | Change from baseline to post-intervention within 1 week | The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis. | ClinicalTrials.gov |
| Secondary | Canadian Occupational Performance Measure (COPM) | Change from post-intervention to 3 month follow-up, within 2 weeks | The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis. | ClinicalTrials.gov |
| Secondary | Canadian Occupational Performance Measure (COPM) | Change from 3 month to 6 month follow-up, within 2 weeks | The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis. | ClinicalTrials.gov |
| Secondary | Canadian Occupational Performance Measure (COPM) | Change from 6 month to 12 month follow-up, within 2 weeks | The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis. | ClinicalTrials.gov |
| Secondary | Stroop Test | Change from post-intervention to 3 month follow-up, within 2 weeks | Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)